Crossmark

Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis

Crossref DOI link: https://doi.org/10.1016/j.medcle.2023.06.009

Published Print: 2023-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Nieto Royo, Rosa

Durán Barata, Diego

Barrios Barreto, Deisy

Briceño Franquiz, Winnifer

Máiz Carro, Luis
License Information

Text and Data Mining valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01

stm-asf valid from 2023-10-01
More Information

This article is maintained by: Elsevier

Article Title: Safety and effectiveness of treatment with elexacaftor, tezacaftor and ivacaftor in adults with cystic fibrosis

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2023.06.009

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2023.06.003

Content Type: article

Copyright: © 2023 Elsevier España, S.L.U. All rights reserved.